Document Detail


Cytotoxic responses to alloantigens in systemic lupus erythematosus.
MedLine Citation:
PMID:  19338096     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We have studied the ability of the peripheral mononuclear cells (MNC) from patients with systemic lupus erythematosus (SLE) to generate a cytotoxic (CML) response against alloantigens. CML responses in SLE patients were significantly lower than those of normal individuals. Mixed lymphocyte reaction (MLR) assays conducted in parallel in these patients were decreased but to a lesser extent. Some of the patients exhibited parallel decreases in both CML and MLR tests, while others showed decreased CML responses but normal MLR responses. Optimal CML responses in SLE patients did not occur at a different time point than in the normals. Plasma from most SLE patients tested did not have an effect on CML and MLR responses of normal MNC; the plasma of only one patient consistently decreased the CML of normal cells. Depletion of adherent cells from MNC of SLE patients by Sephadex G-10 fractionation allowed better CML and MLR responses. Low CML responses in patients with SLE were associated with increased disease activity and increased serum DNA binding. No association between MLR responses in SLE patients and any of the above parameters was detected. SLE patients not having received any cytotoxic treatment exhibited the lowest CML responses, while these under treatment or treated in the past had higher, although not normal, responses. MLR responses were not affected by the treatment status of the patients.
Authors:
G C Tsokos; J E Balow
Related Documents :
20963466 - Association of increased serum il-33 levels with clinical and laboratory characteristic...
6743966 - The frequent occurrence of neurological disease in patients with late-onset systemic lu...
10381046 - Survivorship in a population based cohort of patients with sjögren's syndrome, 1976-1992.
11963576 - Clinical and laboratory features of systemic lupus erythematosus (sle) in pakistani pat...
12781306 - Mutilation anxiety differs among females with fibromyalgia and functional dyspepsia and...
7830176 - Alteration of temporomandibular joint symptoms after orthognathic surgery: comparison w...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of clinical immunology     Volume:  1     ISSN:  0271-9142     ISO Abbreviation:  J. Clin. Immunol.     Publication Date:  1981 Oct 
Date Detail:
Created Date:  2009-04-01     Completed Date:  2009-06-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8102137     Medline TA:  J Clin Immunol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  208-16     Citation Subset:  IM    
Affiliation:
Arthritis and Rheumatism Branch, National Institute of Arthritis, Metabolism and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20205, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Allopurinol / therapeutic use
Cell Separation
Complement C3 / analysis
Cyclophosphamide / therapeutic use
Cytotoxicity Tests, Immunologic
Cytotoxicity, Immunologic*
Humans
Immunosuppressive Agents / therapeutic use
Isoantigens / immunology*
Leukocytes, Mononuclear / immunology*
Lupus Erythematosus, Systemic / blood,  drug therapy,  immunology*
Lymphocyte Activation
Lymphocyte Culture Test, Mixed
Chemical
Reg. No./Substance:
0/Complement C3; 0/Immunosuppressive Agents; 0/Isoantigens; 315-30-0/Allopurinol; 50-18-0/Cyclophosphamide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The serum levels of a soluble form of HLA I molecules in patients with lung cancer
Next Document:  Position of the American Dietetic Association: functional foods.